Process View
Any process that activates or increases the frequency, rate or extent of reactive oxygen species metabolic process.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of reactive oxygen species metabolic process"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
JUN | jun proto-oncogene | 0.915 | ||
EGFR | epidermal growth factor receptor | 0.913 | ||
TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.895 | ||
TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.878 | ||
LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.868 | ||
IL8 | interleukin 8 | 0.863 | ||
ESR1 | estrogen receptor 1 | 0.829 | ||
DUSP1 | dual specificity phosphatase 1 | 0.821 | ||
RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.816 | ||
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.795 | Mouse | |
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.700 | ||
CAV1 | caveolin 1, caveolae protein, 22kDa | 0.686 | ||
SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.657 | ||
SOCS3 | suppressor of cytokine signaling 3 | 0.655 | ||
FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.623 | ||
AKR1C2 | aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III) | 0.603 | Human | |
TICAM2 | toll-like receptor adaptor molecule 2 | 0.579 | ||
FKBP1A | FK506 binding protein 1A, 12kDa | 0.575 | ||
APP | amyloid beta (A4) precursor protein | 0.561 | ||
AKR1C1 | aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) | 0.561 | Human | |
NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.557 | ||
PLAUR | plasminogen activator, urokinase receptor | 0.555 | ||
PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.553 | ||
VEGFA | vascular endothelial growth factor A | 0.468 | Human | |
ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.451 | ||
IL1R1 | interleukin 1 receptor, type I | 0.444 | ||
MAPT | microtubule-associated protein tau | 0.444 | ||
GADD45GIP1 | growth arrest and DNA-damage-inducible, gamma interacting protein 1 | 0.427 | ||
CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.414 | Mouse | |
FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.361 | ||
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.348 | ||
BMP2 | bone morphogenetic protein 2 | 0.337 | ||
NRP1 | neuropilin 1 | 0.333 | ||
BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.333 | Human | |
IGF1R | insulin-like growth factor 1 receptor | 0.318 | ||
JUNB | jun B proto-oncogene | 0.315 | ||
LCK | lymphocyte-specific protein tyrosine kinase | 0.307 | ||
PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.277 | ||
PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.256 | ||
PRDX1 | peroxiredoxin 1 | 0.253 | ||
NOXA1 | NADPH oxidase activator 1 | 0.250 | ||
SMAD7 | SMAD family member 7 | 0.241 | ||
STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.218 | ||
NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.216 | ||
SNTA1 | syntrophin, alpha 1 (dystrophin-associated protein A1, 59kDa, acidic component) | 0.206 | ||
INSR | insulin receptor | 0.203 | ||
KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.202 | ||
AKR1C3 | aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) | 0.202 | ||
PDGFC | platelet derived growth factor C | 0.193 | ||
MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.186 | ||
REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.186 | ||
YAP1 | Yes-associated protein 1 | 0.179 | ||
ARRB1 | arrestin, beta 1 | 0.174 | ||
TGFB3 | transforming growth factor, beta 3 | 0.173 | ||
FYN | FYN oncogene related to SRC, FGR, YES | 0.172 | ||
MEF2A | myocyte enhancer factor 2A | 0.170 | ||
SMAD4 | SMAD family member 4 | 0.168 | ||
ITCH | itchy E3 ubiquitin protein ligase homolog (mouse) | 0.168 | ||
CREBBP | CREB binding protein | 0.167 | ||
KLF6 | Kruppel-like factor 6 | 0.167 | ||
CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.166 | ||
NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.160 | ||
PKN1 | protein kinase N1 | 0.158 | ||
ALDOB | aldolase B, fructose-bisphosphate | 0.155 | ||
PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.155 | ||
ALB | albumin | 0.153 | ||
GOPC | golgi-associated PDZ and coiled-coil motif containing | 0.149 | ||
PLCG1 | phospholipase C, gamma 1 | 0.146 | ||
STAT5A | signal transducer and activator of transcription 5A | 0.143 | ||
PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.138 | ||
AR | androgen receptor | 0.136 | ||
PTEN | phosphatase and tensin homolog | 0.136 | ||
FOSL2 | FOS-like antigen 2 | 0.135 | ||
KLF4 | Kruppel-like factor 4 (gut) | 0.132 | ||
GRB7 | growth factor receptor-bound protein 7 | 0.129 | ||
ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa | 0.124 | ||
MPDZ | multiple PDZ domain protein | 0.122 | ||
IL6 | interleukin 6 (interferon, beta 2) | 0.122 | ||
VAV1 | vav 1 guanine nucleotide exchange factor | 0.121 | ||
FSTL1 | follistatin-like 1 | 0.119 | ||
SOCS1 | suppressor of cytokine signaling 1 | 0.116 | ||
BCL3 | B-cell CLL/lymphoma 3 | 0.115 | ||
ATF2 | activating transcription factor 2 | 0.114 | ||
NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.114 | ||
MAPK14 | mitogen-activated protein kinase 14 | 0.113 | ||
IER2 | immediate early response 2 | 0.107 | ||
GDF5 | growth differentiation factor 5 | 0.105 | ||
ZC3H12A | zinc finger CCCH-type containing 12A | 0.105 | ||
CCND1 | cyclin D1 | 0.105 | ||
MAP2K4 | mitogen-activated protein kinase kinase 4 | 0.102 | ||
FYB | FYN binding protein | 0.101 | ||
GAPDH | glyceraldehyde-3-phosphate dehydrogenase | 0.099 | ||
IFNGR1 | interferon gamma receptor 1 | 0.099 | ||
PKD1 | polycystic kidney disease 1 (autosomal dominant) | 0.099 | ||
FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.098 | ||
BHLHE40 | basic helix-loop-helix family, member e40 | 0.098 | ||
TGFB1 | transforming growth factor, beta 1 | 0.098 | ||
ENG | endoglin | 0.097 | ||
PPP5C | protein phosphatase 5, catalytic subunit | 0.097 | ||
IL1B | interleukin 1, beta | 0.095 | ||
CSRNP1 | cysteine-serine-rich nuclear protein 1 | 0.093 | ||
TGIF1 | TGFB-induced factor homeobox 1 | 0.091 | ||
MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.090 | ||
PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.089 | ||
PPARG | peroxisome proliferator-activated receptor gamma | 0.089 | ||
NCOA1 | nuclear receptor coactivator 1 | 0.089 | ||
CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.087 | Mouse | |
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.087 | ||
PRKCZ | protein kinase C, zeta | 0.086 | Human | |
MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 0.086 | ||
MATK | megakaryocyte-associated tyrosine kinase | 0.085 | ||
HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 | 0.083 | ||
EPOR | erythropoietin receptor | 0.082 | ||
MAPK8 | mitogen-activated protein kinase 8 | 0.082 | Human | |
MYLK2 | myosin light chain kinase 2 | 0.081 | ||
WWOX | WW domain containing oxidoreductase | 0.081 | ||
IL1R2 | interleukin 1 receptor, type II | 0.080 | ||
DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.080 | ||
RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.079 | ||
NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.079 | ||
FGA | fibrinogen alpha chain | 0.077 | ||
IER3 | immediate early response 3 | 0.076 | ||
TRPC1 | transient receptor potential cation channel, subfamily C, member 1 | 0.074 | ||
SQSTM1 | sequestosome 1 | 0.074 | ||
THBS1 | thrombospondin 1 | 0.074 | ||
SH3RF1 | SH3 domain containing ring finger 1 | 0.072 | ||
POLR2L | polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa | 0.072 | ||
YWHAQ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide | 0.072 | ||
CCL20 | chemokine (C-C motif) ligand 20 | 0.071 | ||
ANXA7 | annexin A7 | 0.071 | ||
MIDN | midnolin | 0.070 | ||
JAK2 | Janus kinase 2 | 0.070 | ||
PRKCD | protein kinase C, delta | 0.069 | ||
SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.068 | ||
PLAT | plasminogen activator, tissue | 0.068 | ||
CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.067 | ||
PTPRZ1 | protein tyrosine phosphatase, receptor-type, Z polypeptide 1 | 0.067 | ||
SMAD3 | SMAD family member 3 | 0.067 | ||
CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.067 | ||
CCND3 | cyclin D3 | 0.067 | ||
NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.066 | ||
MLPH | melanophilin | 0.066 | ||
PPP1R15A | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 0.066 | ||
GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.065 | ||
TSC22D1 | TSC22 domain family, member 1 | 0.064 | ||
CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.064 | ||
PARD6G | par-6 partitioning defective 6 homolog gamma (C. elegans) | 0.064 | ||
PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.064 | ||
MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.063 | ||
F3 | coagulation factor III (thromboplastin, tissue factor) | 0.063 | ||
KEAP1 | kelch-like ECH-associated protein 1 | 0.062 | ||
DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.062 | ||
MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.062 | ||
MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.061 | ||
PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.061 | ||
GNAQ | guanine nucleotide binding protein (G protein), q polypeptide | 0.060 | ||
CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.060 | ||
RARA | retinoic acid receptor, alpha | 0.060 | ||
ITK | IL2-inducible T-cell kinase | 0.060 | ||
BIRC3 | baculoviral IAP repeat containing 3 | 0.060 | ||
TRADD | TNFRSF1A-associated via death domain | 0.060 | ||
KAT2B | K(lysine) acetyltransferase 2B | 0.058 | ||
IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.058 | ||
ATF3 | activating transcription factor 3 | 0.057 | ||
ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0.056 | ||
PICK1 | protein interacting with PRKCA 1 | 0.056 | ||
JAG1 | jagged 1 | 0.055 | ||
KLF10 | Kruppel-like factor 10 | 0.055 | ||
NCOA2 | nuclear receptor coactivator 2 | 0.055 | ||
ANKS1B | ankyrin repeat and sterile alpha motif domain containing 1B | 0.055 | ||
NAMPT | nicotinamide phosphoribosyltransferase | 0.054 | ||
MAP1LC3A | microtubule-associated protein 1 light chain 3 alpha | 0.054 | ||
CDCP1 | CUB domain containing protein 1 | 0.054 | ||
SMAD2 | SMAD family member 2 | 0.054 | ||
CDK6 | cyclin-dependent kinase 6 | 0.053 | ||
CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 0.053 | ||
NCOA3 | nuclear receptor coactivator 3 | 0.053 | ||
GRB2 | growth factor receptor-bound protein 2 | 0.053 | ||
SATB2 | SATB homeobox 2 | 0.052 | ||
PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0.052 | ||
KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.052 | ||
CTBP1 | C-terminal binding protein 1 | 0.051 | ||
YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.051 | ||
BAD | BCL2-associated agonist of cell death | 0.050 | ||
PRKG1 | protein kinase, cGMP-dependent, type I | 0.050 | ||
SYTL4 | synaptotagmin-like 4 | 0.050 | ||
ZMYND11 | zinc finger, MYND-type containing 11 | 0.050 | ||
ACVR1 | activin A receptor, type I | 0.050 | Human | |
IRS2 | insulin receptor substrate 2 | 0.049 | ||
IRAK2 | interleukin-1 receptor-associated kinase 2 | 0.049 | ||
FAS | Fas (TNF receptor superfamily, member 6) | 0.048 | ||
LAT | linker for activation of T cells | 0.047 | ||
PDGFA | platelet-derived growth factor alpha polypeptide | 0.047 | Human | |
CPNE6 | copine VI (neuronal) | 0.047 | ||
S100B | S100 calcium binding protein B | 0.047 | ||
SKP1 | S-phase kinase-associated protein 1 | 0.046 | ||
MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) | 0.046 | ||
CCND2 | cyclin D2 | 0.046 | ||
MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.046 | ||
ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.046 | ||
SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.045 | ||
CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 0.045 | ||
CABLES1 | Cdk5 and Abl enzyme substrate 1 | 0.045 | ||
MEF2C | myocyte enhancer factor 2C | 0.045 | ||
ADM | adrenomedullin | 0.045 | ||
LDLR | low density lipoprotein receptor | 0.045 | ||
APBB1 | amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) | 0.043 | ||
BCL10 | B-cell CLL/lymphoma 10 | 0.043 | ||
CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.043 | ||
SOD1 | superoxide dismutase 1, soluble | 0.043 | ||
PGF | placental growth factor | 0.043 | Human | |
CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.043 | ||
TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.042 | ||
NR2E3 | nuclear receptor subfamily 2, group E, member 3 | 0.042 | ||
MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.041 | ||
SSTR3 | somatostatin receptor 3 | 0.041 | ||
INHBA | inhibin, beta A | 0.041 | ||
PAFAH1B1 | platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa) | 0.041 | ||
ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.040 | ||
RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | 0.040 | ||
NCK1 | NCK adaptor protein 1 | 0.040 | ||
MAPK15 | mitogen-activated protein kinase 15 | 0.040 | ||
PSEN1 | presenilin 1 | 0.040 | ||
PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.040 | ||
EDN1 | endothelin 1 | 0.040 | ||
EGR1 | early growth response 1 | 0.039 | ||
IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.039 | ||
JAK3 | Janus kinase 3 | 0.039 | ||
CD55 | CD55 molecule, decay accelerating factor for complement (Cromer blood group) | 0.039 | ||
CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.039 | ||
NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.039 | ||
SNCAIP | synuclein, alpha interacting protein | 0.039 | ||
ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.039 | ||
RHOB | ras homolog gene family, member B | 0.038 | ||
MXD1 | MAX dimerization protein 1 | 0.038 | ||
KRT5 | keratin 5 | 0.038 | ||
NUMB | numb homolog (Drosophila) | 0.038 | ||
GZMA | granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) | 0.038 | ||
SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.038 | ||
MPRIP | myosin phosphatase Rho interacting protein | 0.038 | ||
GAB1 | GRB2-associated binding protein 1 | 0.038 | ||
DLG2 | discs, large homolog 2 (Drosophila) | 0.038 | ||
TFPI | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | 0.038 | ||
GFAP | glial fibrillary acidic protein | 0.037 | ||
OSMR | oncostatin M receptor | 0.037 | ||
DUSP23 | dual specificity phosphatase 23 | 0.037 | ||
SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.037 | ||
SH3BP2 | SH3-domain binding protein 2 | 0.037 | ||
PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.037 | ||
ERBB4 | v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) | 0.037 | ||
USMG5 | up-regulated during skeletal muscle growth 5 homolog (mouse) | 0.037 | ||
MAP3K4 | mitogen-activated protein kinase kinase kinase 4 | 0.037 | ||
TXN | thioredoxin | 0.037 | ||
TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.037 | ||
CFLAR | CASP8 and FADD-like apoptosis regulator | 0.036 | ||
LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.036 | ||
CAV2 | caveolin 2 | 0.036 | ||
BMPR1A | bone morphogenetic protein receptor, type IA | 0.036 | Human | |
ACSL1 | acyl-CoA synthetase long-chain family member 1 | 0.036 | ||
IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.036 | ||
PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 | 0.036 | ||
SPRED1 | sprouty-related, EVH1 domain containing 1 | 0.036 | ||
XPO7 | exportin 7 | 0.035 | ||
SP1 | Sp1 transcription factor | 0.035 | ||
AHSG | alpha-2-HS-glycoprotein | 0.035 | ||
RB1 | retinoblastoma 1 | 0.035 | ||
MYO1C | myosin IC | 0.035 | ||
EPAS1 | endothelial PAS domain protein 1 | 0.035 | ||
CCNE1 | cyclin E1 | 0.035 | ||
YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 0.035 | ||
NFIL3 | nuclear factor, interleukin 3 regulated | 0.035 | ||
HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.034 | ||
CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.034 | ||
MBNL2 | muscleblind-like 2 (Drosophila) | 0.034 | ||
NCOA6 | nuclear receptor coactivator 6 | 0.034 | ||
SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.034 | ||
CSF3 | colony stimulating factor 3 (granulocyte) | 0.034 | ||
ZBP1 | Z-DNA binding protein 1 | 0.034 | ||
YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.034 | ||
PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.033 | ||
ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 0.033 | ||
CBLC | Cas-Br-M (murine) ecotropic retroviral transforming sequence c | 0.033 | ||
TRO | trophinin | 0.033 | ||
AKTIP | AKT interacting protein | 0.033 | ||
KRT6C | keratin 6C | 0.033 | ||
TTR | transthyretin | 0.033 | ||
CRIM1 | cysteine rich transmembrane BMP regulator 1 (chordin-like) | 0.033 | ||
MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 | 0.033 | ||
EREG | epiregulin | 0.033 | ||
CCL7 | chemokine (C-C motif) ligand 7 | 0.033 | ||
SYN1 | synapsin I | 0.033 | ||
F11R | F11 receptor | 0.033 | ||
GLS | glutaminase | 0.033 | ||
RUNX1 | runt-related transcription factor 1 | 0.032 | ||
HP | haptoglobin | 0.032 | ||
CCL2 | chemokine (C-C motif) ligand 2 | 0.032 | ||
CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.032 | Mouse | |
IL1RAP | interleukin 1 receptor accessory protein | 0.032 | ||
IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.032 | ||
PRDX6 | peroxiredoxin 6 | 0.032 | ||
ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.032 | ||
CCL4 | chemokine (C-C motif) ligand 4 | 0.032 | ||
PCDHA4 | protocadherin alpha 4 | 0.032 | ||
CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 0.032 | Human | |
UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.032 | ||
IRS1 | insulin receptor substrate 1 | 0.032 | ||
BCL6 | B-cell CLL/lymphoma 6 | 0.032 | ||
IL1RN | interleukin 1 receptor antagonist | 0.032 | ||
SCAMP1 | secretory carrier membrane protein 1 | 0.031 | ||
WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.031 | ||
RECK | reversion-inducing-cysteine-rich protein with kazal motifs | 0.031 | ||
FGFR1 | fibroblast growth factor receptor 1 | 0.031 | ||
MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.031 | ||
MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.031 | ||
SESN2 | sestrin 2 | 0.031 | ||
UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.031 | ||
FABP4 | fatty acid binding protein 4, adipocyte | 0.031 | ||
CALD1 | caldesmon 1 | 0.031 | ||
SKIL | SKI-like oncogene | 0.031 | ||
ZNF71 | zinc finger protein 71 | 0.031 | ||
BMP4 | bone morphogenetic protein 4 | 0.030 | ||
IL4R | interleukin 4 receptor | 0.030 | ||
FOSL1 | FOS-like antigen 1 | 0.030 | ||
CUL7 | cullin 7 | 0.030 | ||
DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.030 | ||
APOB | apolipoprotein B (including Ag(x) antigen) | 0.030 | ||
SERPINA5 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | 0.030 | ||
VTN | vitronectin | 0.030 | ||
CCNL1 | cyclin L1 | 0.030 | ||
LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.030 | ||
IL12RB2 | interleukin 12 receptor, beta 2 | 0.030 | ||
CD2 | CD2 molecule | 0.030 | ||
WWTR1 | WW domain containing transcription regulator 1 | 0.030 | ||
GK | glycerol kinase | 0.030 | ||
RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.030 | ||
SMAD1 | SMAD family member 1 | 0.029 | ||
NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.029 | ||
BTG2 | BTG family, member 2 | 0.029 | ||
CD247 | CD247 molecule | 0.029 | ||
ORM1 | orosomucoid 1 | 0.029 | ||
TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.029 | ||
JUND | jun D proto-oncogene | 0.029 | ||
CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.029 | ||
IL18RAP | interleukin 18 receptor accessory protein | 0.029 | ||
SPRR2A | small proline-rich protein 2A | 0.029 | ||
FGF7 | fibroblast growth factor 7 | 0.029 | ||
PARK7 | Parkinson disease (autosomal recessive, early onset) 7 | 0.029 | ||
DDX17 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 | 0.029 | ||
SGK3 | serum/glucocorticoid regulated kinase family, member 3 | 0.029 | ||
DUSP9 | dual specificity phosphatase 9 | 0.029 | ||
TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.029 | ||
MGEA5 | meningioma expressed antigen 5 (hyaluronidase) | 0.028 | ||
MED25 | mediator complex subunit 25 | 0.028 | ||
GATA1 | GATA binding protein 1 (globin transcription factor 1) | 0.028 | ||
RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.028 | ||
PTPN14 | protein tyrosine phosphatase, non-receptor type 14 | 0.028 | ||
PTHLH | parathyroid hormone-like hormone | 0.028 | ||
BCL2A1 | BCL2-related protein A1 | 0.028 | ||
SLPI | secretory leukocyte peptidase inhibitor | 0.028 | ||
COL5A1 | collagen, type V, alpha 1 | 0.028 | ||
PIM1 | pim-1 oncogene | 0.028 | ||
PI3 | peptidase inhibitor 3, skin-derived | 0.028 | ||
CCDC115 | coiled-coil domain containing 115 | 0.027 | ||
GCGR | glucagon receptor | 0.027 | ||
CHRNA4 | cholinergic receptor, nicotinic, alpha 4 | 0.027 | ||
NCOR1 | nuclear receptor corepressor 1 | 0.027 | ||
SERTAD1 | SERTA domain containing 1 | 0.027 | ||
SAT1 | spermidine/spermine N1-acetyltransferase 1 | 0.027 | ||
SYK | spleen tyrosine kinase | 0.027 | ||
PTX3 | pentraxin 3, long | 0.027 | ||
CCL14 | chemokine (C-C motif) ligand 14 | 0.027 | ||
TEAD1 | TEA domain family member 1 (SV40 transcriptional enhancer factor) | 0.027 | ||
EIF2AK3 | eukaryotic translation initiation factor 2-alpha kinase 3 | 0.027 | ||
PRODH2 | proline dehydrogenase (oxidase) 2 | 0.027 | ||
AKT3 | v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) | 0.027 | Human | |
SGK1 | serum/glucocorticoid regulated kinase 1 | 0.027 | ||
VHL | von Hippel-Lindau tumor suppressor | 0.027 | ||
ARG1 | arginase, liver | 0.027 | ||
FGG | fibrinogen gamma chain | 0.027 | ||
S100A12 | S100 calcium binding protein A12 | 0.027 | ||
APOA1 | apolipoprotein A-I | 0.026 | ||
TGFB2 | transforming growth factor, beta 2 | 0.026 | Human | |
CSF3R | colony stimulating factor 3 receptor (granulocyte) | 0.026 | ||
MARK2 | MAP/microtubule affinity-regulating kinase 2 | 0.026 | ||
VAV3 | vav 3 guanine nucleotide exchange factor | 0.026 | ||
DAXX | death-domain associated protein | 0.026 | ||
USP15 | ubiquitin specific peptidase 15 | 0.026 | ||
CHCHD2 | coiled-coil-helix-coiled-coil-helix domain containing 2 | 0.026 | ||
PTPN4 | protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte) | 0.026 | ||
DUSP2 | dual specificity phosphatase 2 | 0.026 | ||
FOXO1 | forkhead box O1 | 0.026 | ||
S100A1 | S100 calcium binding protein A1 | 0.026 | ||
SH2D2A | SH2 domain containing 2A | 0.026 | ||
DAB2IP | DAB2 interacting protein | 0.026 | ||
DARC | Duffy blood group, chemokine receptor | 0.026 | ||
APLP1 | amyloid beta (A4) precursor-like protein 1 | 0.026 | ||
KCNA1 | potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) | 0.026 | ||
CCL1 | chemokine (C-C motif) ligand 1 | 0.026 | ||
HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.025 | ||
BIN2 | bridging integrator 2 | 0.025 | ||
TP53 | tumor protein p53 | 0.025 | ||
MAPK9 | mitogen-activated protein kinase 9 | 0.025 | Human | |
PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.025 | ||
PIAS4 | protein inhibitor of activated STAT, 4 | 0.025 | ||
COL4A1 | collagen, type IV, alpha 1 | 0.025 | ||
MMP16 | matrix metallopeptidase 16 (membrane-inserted) | 0.025 | ||
LLGL1 | lethal giant larvae homolog 1 (Drosophila) | 0.025 | ||
MRPL53 | mitochondrial ribosomal protein L53 | 0.025 | ||
SCARB2 | scavenger receptor class B, member 2 | 0.025 | ||
VNN1 | vanin 1 | 0.025 | ||
DYNLL1 | dynein, light chain, LC8-type 1 | 0.025 | ||
SHANK1 | SH3 and multiple ankyrin repeat domains 1 | 0.025 | ||
SSTR2 | somatostatin receptor 2 | 0.025 | ||
SPOCK1 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 | 0.025 | ||
SAMD4B | sterile alpha motif domain containing 4B | 0.025 | ||
CTBP2 | C-terminal binding protein 2 | 0.025 | ||
LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.025 | ||
VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.025 | ||
ARRB2 | arrestin, beta 2 | 0.025 | ||
BCL2L1 | BCL2-like 1 | 0.025 | ||
HNF4A | hepatocyte nuclear factor 4, alpha | 0.025 | ||
CEACAM1 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | 0.025 | ||
PDZK1 | PDZ domain containing 1 | 0.025 | ||
PPP1R13B | protein phosphatase 1, regulatory (inhibitor) subunit 13B | 0.025 | ||
TEK | TEK tyrosine kinase, endothelial | 0.025 | ||
TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.025 | ||
COL6A1 | collagen, type VI, alpha 1 | 0.025 | ||
LY96 | lymphocyte antigen 96 | 0.025 | ||
MAPK11 | mitogen-activated protein kinase 11 | 0.025 | Human | |
GSK3B | glycogen synthase kinase 3 beta | 0.024 | ||
MYO5A | myosin VA (heavy chain 12, myoxin) | 0.024 | ||
PPP1CC | protein phosphatase 1, catalytic subunit, gamma isozyme | 0.024 | ||
DLG4 | discs, large homolog 4 (Drosophila) | 0.024 | ||
WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.024 | ||
F7 | coagulation factor VII (serum prothrombin conversion accelerator) | 0.024 | Human | |
DBI | diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) | 0.024 | ||
GNA15 | guanine nucleotide binding protein (G protein), alpha 15 (Gq class) | 0.024 | ||
F10 | coagulation factor X | 0.024 | Human | |
POU2F2 | POU class 2 homeobox 2 | 0.024 | ||
S1PR5 | sphingosine-1-phosphate receptor 5 | 0.024 | ||
TSC2 | tuberous sclerosis 2 | 0.024 | ||
CARD11 | caspase recruitment domain family, member 11 | 0.024 | ||
FOXO3 | forkhead box O3 | 0.024 | ||
DLC1 | deleted in liver cancer 1 | 0.024 | ||
CHMP4B | chromatin modifying protein 4B | 0.024 | ||
CITED1 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 | 0.024 | ||
SLC2A4 | solute carrier family 2 (facilitated glucose transporter), member 4 | 0.024 | ||
TTC1 | tetratricopeptide repeat domain 1 | 0.024 | ||
MYO1D | myosin ID | 0.024 | ||
SLC6A3 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 0.024 | ||
TPPP | tubulin polymerization promoting protein | 0.024 | ||
GDA | guanine deaminase | 0.023 | ||
P2RY13 | purinergic receptor P2Y, G-protein coupled, 13 | 0.023 | ||
GAB2 | GRB2-associated binding protein 2 | 0.023 | ||
TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.023 | ||
COL2A1 | collagen, type II, alpha 1 | 0.023 | ||
MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | 0.023 | ||
CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 0.023 | ||
AHR | aryl hydrocarbon receptor | 0.023 | ||
HCFC1 | host cell factor C1 (VP16-accessory protein) | 0.023 | ||
MAX | MYC associated factor X | 0.023 | ||
RYK | RYK receptor-like tyrosine kinase | 0.023 | ||
BAG3 | BCL2-associated athanogene 3 | 0.023 | ||
CFB | complement factor B | 0.023 | ||
PDK4 | pyruvate dehydrogenase kinase, isozyme 4 | 0.023 | ||
SEMA3C | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C | 0.023 | ||
DNAJB1 | DnaJ (Hsp40) homolog, subfamily B, member 1 | 0.023 | ||
ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 | 0.023 | ||
CYLD | cylindromatosis (turban tumor syndrome) | 0.023 | ||
ADRA1D | adrenergic, alpha-1D-, receptor | 0.023 | ||
TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.023 | ||
B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 | 0.023 | ||
MUC1 | mucin 1, cell surface associated | 0.023 | ||
SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 0.023 | ||
EDEM3 | ER degradation enhancer, mannosidase alpha-like 3 | 0.023 | ||
FLT4 | fms-related tyrosine kinase 4 | 0.023 | ||
IL7R | interleukin 7 receptor | 0.022 | ||
TRIM9 | tripartite motif containing 9 | 0.022 | ||
CEACAM6 | carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | 0.022 | ||
FILIP1L | filamin A interacting protein 1-like | 0.022 | ||
SASH3 | SAM and SH3 domain containing 3 | 0.022 | ||
IL1A | interleukin 1, alpha | 0.022 | ||
LRRK2 | leucine-rich repeat kinase 2 | 0.022 | ||
FPR1 | formyl peptide receptor 1 | 0.022 | ||
HPX | hemopexin | 0.022 | ||
PTPRE | protein tyrosine phosphatase, receptor type, E | 0.022 | ||
NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.022 | ||
EIF4A2 | eukaryotic translation initiation factor 4A2 | 0.022 | ||
F2 | coagulation factor II (thrombin) | 0.022 | ||
FABP1 | fatty acid binding protein 1, liver | 0.022 | ||
SMAD6 | SMAD family member 6 | 0.022 | ||
STC1 | stanniocalcin 1 | 0.022 | ||
OBSL1 | obscurin-like 1 | 0.022 | ||
ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.022 | ||
DOCK9 | dedicator of cytokinesis 9 | 0.022 | ||
PNMA1 | paraneoplastic antigen MA1 | 0.022 | ||
SPTBN1 | spectrin, beta, non-erythrocytic 1 | 0.022 | ||
IGFALS | insulin-like growth factor binding protein, acid labile subunit | 0.022 | ||
PNOC | prepronociceptin | 0.022 | ||
GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.022 | ||
DCTN2 | dynactin 2 (p50) | 0.022 | ||
TBL1XR1 | transducin (beta)-like 1 X-linked receptor 1 | 0.022 | ||
PRDM1 | PR domain containing 1, with ZNF domain | 0.022 | ||
ITIH3 | inter-alpha (globulin) inhibitor H3 | 0.022 | ||
KCNF1 | potassium voltage-gated channel, subfamily F, member 1 | 0.022 | ||
CACNA1A | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | 0.022 | ||
ARFGEF1 | ADP-ribosylation factor guanine nucleotide-exchange factor 1(brefeldin A-inhibited) | 0.022 | ||
HINT1 | histidine triad nucleotide binding protein 1 | 0.022 | ||
GRM5 | glutamate receptor, metabotropic 5 | 0.022 | ||
IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.022 | ||
LAMB3 | laminin, beta 3 | 0.022 | ||
PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.022 | ||
GPR171 | G protein-coupled receptor 171 | 0.022 | ||
ALPI | alkaline phosphatase, intestinal | 0.022 | ||
RUNX2 | runt-related transcription factor 2 | 0.022 | ||
SERPINA10 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 | 0.022 | ||
TSG101 | tumor susceptibility gene 101 | 0.022 | ||
KIF1C | kinesin family member 1C | 0.022 | ||
RGS1 | regulator of G-protein signaling 1 | 0.022 | ||
AGTR1 | angiotensin II receptor, type 1 | 0.022 | Rat | |
FGF2 | fibroblast growth factor 2 (basic) | 0.022 | ||
MATN4 | matrilin 4 | 0.022 | ||
GABRR2 | gamma-aminobutyric acid (GABA) receptor, rho 2 | 0.021 | ||
TXNRD1 | thioredoxin reductase 1 | 0.021 | ||
CDKN2B | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | 0.021 | ||
SEPT11 | septin 11 | 0.021 | ||
EFNB2 | ephrin-B2 | 0.021 | ||
SPRR1B | small proline-rich protein 1B | 0.021 | ||
RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.021 | ||
SLC38A3 | solute carrier family 38, member 3 | 0.021 | ||
GRK1 | G protein-coupled receptor kinase 1 | 0.021 | ||
NLRP3 | NLR family, pyrin domain containing 3 | 0.021 | ||
FNDC3B | fibronectin type III domain containing 3B | 0.021 | ||
BMP10 | bone morphogenetic protein 10 | 0.021 | ||
GHRHR | growth hormone releasing hormone receptor | 0.021 | ||
S100P | S100 calcium binding protein P | 0.021 | ||
TCF21 | transcription factor 21 | 0.021 | ||
GPRASP1 | G protein-coupled receptor associated sorting protein 1 | 0.021 | ||
TREM1 | triggering receptor expressed on myeloid cells 1 | 0.021 | ||
HSPA1B | heat shock 70kDa protein 1B | 0.021 | ||
IKZF1 | IKAROS family zinc finger 1 (Ikaros) | 0.021 | ||
LEPR | leptin receptor | 0.021 | ||
C14orf43 | chromosome 14 open reading frame 43 | 0.021 | ||
SERPINA4 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 | 0.021 | ||
C20orf151 | chromosome 20 open reading frame 151 | 0.021 | ||
TSC22D3 | TSC22 domain family, member 3 | 0.021 | ||
ACVR2A | activin A receptor, type IIA | 0.021 | ||
PTGER4 | prostaglandin E receptor 4 (subtype EP4) | 0.021 | ||
VSIG4 | V-set and immunoglobulin domain containing 4 | 0.021 | ||
CD33 | CD33 molecule | 0.021 | ||
RBMS3 | RNA binding motif, single stranded interacting protein 3 | 0.021 | ||
SHH | sonic hedgehog | 0.021 | ||
EBI3 | Epstein-Barr virus induced 3 | 0.021 | ||
BACH1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 | 0.021 | ||
TGFBR3 | transforming growth factor, beta receptor III | 0.021 | ||
LBP | lipopolysaccharide binding protein | 0.021 | ||
PTGER2 | prostaglandin E receptor 2 (subtype EP2), 53kDa | 0.021 | ||
HIVEP1 | human immunodeficiency virus type I enhancer binding protein 1 | 0.021 | ||
GREM1 | gremlin 1 | 0.021 | ||
ARHGAP12 | Rho GTPase activating protein 12 | 0.021 | ||
HBQ1 | hemoglobin, theta 1 | 0.021 | ||
CRYAB | crystallin, alpha B | 0.021 | ||
SNTB2 | syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2) | 0.021 | ||
DOK4 | docking protein 4 | 0.021 | ||
BMPR1B | bone morphogenetic protein receptor, type IB | 0.021 | Human | |
INADL | InaD-like (Drosophila) | 0.021 | ||
OPRD1 | opioid receptor, delta 1 | 0.021 | ||
SRPK3 | SRSF protein kinase 3 | 0.021 | ||
LAMC2 | laminin, gamma 2 | 0.021 | ||
SERPINB1 | serpin peptidase inhibitor, clade B (ovalbumin), member 1 | 0.021 | ||
BTK | Bruton agammaglobulinemia tyrosine kinase | 0.021 | ||
WISP2 | WNT1 inducible signaling pathway protein 2 | 0.021 | ||
KLF7 | Kruppel-like factor 7 (ubiquitous) | 0.020 | ||
TALDO1 | transaldolase 1 | 0.020 | ||
NNMT | nicotinamide N-methyltransferase | 0.020 | ||
KISS1 | KiSS-1 metastasis-suppressor | 0.020 | ||
LIMA1 | LIM domain and actin binding 1 | 0.020 | ||
IGFBP1 | insulin-like growth factor binding protein 1 | 0.020 | ||
MAP2K6 | mitogen-activated protein kinase kinase 6 | 0.020 | ||
LAMA4 | laminin, alpha 4 | 0.020 | ||
TRIM8 | tripartite motif containing 8 | 0.020 | ||
ARRDC3 | arrestin domain containing 3 | 0.020 | ||
PRRX1 | paired related homeobox 1 | 0.020 | ||
TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.020 | ||
FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.020 | ||
UGCG | UDP-glucose ceramide glucosyltransferase | 0.020 | ||
CLCA2 | chloride channel accessory 2 | 0.020 | ||
ANTXR2 | anthrax toxin receptor 2 | 0.020 | ||
GCH1 | GTP cyclohydrolase 1 | 0.020 | ||
LEP | leptin | 0.020 | ||
FGL1 | fibrinogen-like 1 | 0.020 | ||
NRP2 | neuropilin 2 | 0.020 | ||
COL8A1 | collagen, type VIII, alpha 1 | 0.020 | ||
MAPKAPK3 | mitogen-activated protein kinase-activated protein kinase 3 | 0.020 | ||
DDIT4 | DNA-damage-inducible transcript 4 | 0.020 | ||
GPR109B | G protein-coupled receptor 109B | 0.020 | ||
SLC4A1 | solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) | 0.020 | ||
FLT3 | fms-related tyrosine kinase 3 | 0.020 | ||
XPNPEP1 | X-prolyl aminopeptidase (aminopeptidase P) 1, soluble | 0.020 | ||
GRIN2A | glutamate receptor, ionotropic, N-methyl D-aspartate 2A | 0.020 | ||
ZHX1 | zinc fingers and homeoboxes 1 | 0.020 | ||
PAWR | PRKC, apoptosis, WT1, regulator | 0.020 | ||
HBZ | hemoglobin, zeta | 0.020 | ||
ANKS1A | ankyrin repeat and sterile alpha motif domain containing 1A | 0.020 | ||
ACSM2B | acyl-CoA synthetase medium-chain family member 2B | 0.020 | ||
ZEB1 | zinc finger E-box binding homeobox 1 | 0.020 | ||
MBD2 | methyl-CpG binding domain protein 2 | 0.020 | ||
SH2B2 | SH2B adaptor protein 2 | 0.020 | ||
SIK1 | salt-inducible kinase 1 | 0.020 | ||
RAI14 | retinoic acid induced 14 | 0.020 | ||
KNG1 | kininogen 1 | 0.020 | ||
MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | 0.020 | ||
SYT9 | synaptotagmin IX | 0.020 | ||
ID2 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | 0.020 | ||
PROCR | protein C receptor, endothelial | 0.020 | ||
GHR | growth hormone receptor | 0.020 | ||
COL10A1 | collagen, type X, alpha 1 | 0.020 | ||
APPL2 | adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 | 0.020 | ||
CCL22 | chemokine (C-C motif) ligand 22 | 0.020 | ||
SAP18 | Sin3A-associated protein, 18kDa | 0.020 | ||
NRG1 | neuregulin 1 | 0.020 | ||
HIVEP2 | human immunodeficiency virus type I enhancer binding protein 2 | 0.020 | ||
IL13RA1 | interleukin 13 receptor, alpha 1 | 0.020 | ||
ARIH2 | ariadne homolog 2 (Drosophila) | 0.020 | ||
LLGL2 | lethal giant larvae homolog 2 (Drosophila) | 0.020 | ||
GRIN2C | glutamate receptor, ionotropic, N-methyl D-aspartate 2C | 0.020 | ||
SLIT2 | slit homolog 2 (Drosophila) | 0.020 | ||
HDAC1 | histone deacetylase 1 | 0.020 | ||
MYO1B | myosin IB | 0.020 | ||
IGFBP5 | insulin-like growth factor binding protein 5 | 0.020 | ||
TPST1 | tyrosylprotein sulfotransferase 1 | 0.019 | ||
DTX1 | deltex homolog 1 (Drosophila) | 0.019 | ||
ADRB2 | adrenergic, beta-2-, receptor, surface | 0.019 | ||
SYTL2 | synaptotagmin-like 2 | 0.019 | ||
GADD45B | growth arrest and DNA-damage-inducible, beta | 0.019 | Human | |
SERPINA3 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 | 0.019 | ||
MAFK | v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) | 0.019 | ||
RND3 | Rho family GTPase 3 | 0.019 | ||
TFR2 | transferrin receptor 2 | 0.019 | ||
CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.019 | ||
EDNRB | endothelin receptor type B | 0.019 | ||
HEG1 | HEG homolog 1 (zebrafish) | 0.019 | ||
RET | ret proto-oncogene | 0.019 | ||
ANGPT2 | angiopoietin 2 | 0.019 | ||
ZFP36L1 | zinc finger protein 36, C3H type-like 1 | 0.019 | ||
INHA | inhibin, alpha | 0.019 | ||
PRKCB | protein kinase C, beta | 0.019 | ||
CCIN | calicin | 0.019 | ||
SBNO2 | strawberry notch homolog 2 (Drosophila) | 0.019 | ||
NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.019 | ||
CRP | C-reactive protein, pentraxin-related | 0.019 | ||
AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.019 | Human | |
GFER | growth factor, augmenter of liver regeneration | 0.019 | ||
ITIH4 | inter-alpha (globulin) inhibitor H4 (plasma Kallikrein-sensitive glycoprotein) | 0.019 | ||
BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | 0.019 | ||
MAP2 | microtubule-associated protein 2 | 0.019 | ||
TADA3 | transcriptional adaptor 3 | 0.019 | ||
SDPR | serum deprivation response | 0.019 | ||
LCP1 | lymphocyte cytosolic protein 1 (L-plastin) | 0.019 | ||
DUSP4 | dual specificity phosphatase 4 | 0.019 | ||
DPF1 | D4, zinc and double PHD fingers family 1 | 0.019 | ||
RBL2 | retinoblastoma-like 2 (p130) | 0.019 | ||
CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.019 | ||
RCAN1 | regulator of calcineurin 1 | 0.019 | ||
SAA4 | serum amyloid A4, constitutive | 0.019 | ||
DOCK7 | dedicator of cytokinesis 7 | 0.019 | ||
UBL5 | ubiquitin-like 5 | 0.019 | ||
FOXN1 | forkhead box N1 | 0.019 | ||
SPTAN1 | spectrin, alpha, non-erythrocytic 1 (alpha-fodrin) | 0.019 | ||
MTA3 | metastasis associated 1 family, member 3 | 0.019 | ||
FCGR2C | Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) | 0.019 | ||
GATAD2B | GATA zinc finger domain containing 2B | 0.019 | ||
CELF3 | CUGBP, Elav-like family member 3 | 0.019 | ||
TCF15 | transcription factor 15 (basic helix-loop-helix) | 0.019 | ||
MAP2K7 | mitogen-activated protein kinase kinase 7 | 0.019 | ||
SNX13 | sorting nexin 13 | 0.019 | ||
TSC22D4 | TSC22 domain family, member 4 | 0.019 | ||
ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 0.019 | ||
APOA2 | apolipoprotein A-II | 0.019 | ||
SERPINE2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 | 0.019 | ||
S100A8 | S100 calcium binding protein A8 | 0.019 | ||
ARHGAP25 | Rho GTPase activating protein 25 | 0.019 | ||
ANXA3 | annexin A3 | 0.019 | ||
KLRG1 | killer cell lectin-like receptor subfamily G, member 1 | 0.019 | ||
ACPP | acid phosphatase, prostate | 0.019 | ||
MIF4GD | MIF4G domain containing | 0.019 | ||
SLC12A3 | solute carrier family 12 (sodium/chloride transporters), member 3 | 0.019 | ||
MSC | musculin | 0.019 | ||
PDE4B | phosphodiesterase 4B, cAMP-specific | 0.019 | ||
LCN2 | lipocalin 2 | 0.019 | ||
GNG11 | guanine nucleotide binding protein (G protein), gamma 11 | 0.019 | ||
KDM3B | lysine (K)-specific demethylase 3B | 0.019 | ||
HNF1A | HNF1 homeobox A | 0.019 | ||
PRL | prolactin | 0.019 | ||
SNX18 | sorting nexin 18 | 0.019 | ||
SPG20 | spastic paraplegia 20 (Troyer syndrome) | 0.019 | ||
C1orf63 | chromosome 1 open reading frame 63 | 0.019 | ||
PRF1 | perforin 1 (pore forming protein) | 0.019 | ||
GSN | gelsolin | 0.019 | ||
HIC1 | hypermethylated in cancer 1 | 0.019 | ||
TLX1 | T-cell leukemia homeobox 1 | 0.019 | ||
APOC3 | apolipoprotein C-III | 0.019 | ||
ZNF676 | zinc finger protein 676 | 0.019 | ||
HBEGF | heparin-binding EGF-like growth factor | 0.019 | ||
MYL4 | myosin, light chain 4, alkali; atrial, embryonic | 0.019 | ||
GPRASP2 | G protein-coupled receptor associated sorting protein 2 | 0.019 | ||
PIM3 | pim-3 oncogene | 0.019 | ||
NCOR2 | nuclear receptor corepressor 2 | 0.019 | ||
TNFRSF11B | tumor necrosis factor receptor superfamily, member 11b | 0.019 | ||
JDP2 | Jun dimerization protein 2 | 0.019 | ||
IL1F9 | interleukin 1 family, member 9 | 0.019 | ||
SEPT4 | septin 4 | 0.018 | ||
TNIP2 | TNFAIP3 interacting protein 2 | 0.018 | ||
HTR6 | 5-hydroxytryptamine (serotonin) receptor 6 | 0.018 | ||
GDF2 | growth differentiation factor 2 | 0.018 | ||
ALOX12 | arachidonate 12-lipoxygenase | 0.018 | ||
PLG | plasminogen | 0.018 | ||
STAT4 | signal transducer and activator of transcription 4 | 0.018 | ||
CHRNA6 | cholinergic receptor, nicotinic, alpha 6 | 0.018 | ||
MICA | MHC class I polypeptide-related sequence A | 0.018 | ||
POFUT1 | protein O-fucosyltransferase 1 | 0.018 | ||
ZEB2 | zinc finger E-box binding homeobox 2 | 0.018 | ||
SRSF5 | serine/arginine-rich splicing factor 5 | 0.018 | ||
FUS | fused in sarcoma | 0.018 | ||
MMP25 | matrix metallopeptidase 25 | 0.018 | ||
RAPGEF2 | Rap guanine nucleotide exchange factor (GEF) 2 | 0.018 | ||
UBE2Z | ubiquitin-conjugating enzyme E2Z | 0.018 | ||
DLG3 | discs, large homolog 3 (Drosophila) | 0.018 | ||
CDK14 | cyclin-dependent kinase 14 | 0.018 | ||
ASGR1 | asialoglycoprotein receptor 1 | 0.018 | ||
SS18 | synovial sarcoma translocation, chromosome 18 | 0.018 | ||
CLEC4M | C-type lectin domain family 4, member M | 0.018 | ||
RNF166 | ring finger protein 166 | 0.018 | ||
VEGFC | vascular endothelial growth factor C | 0.018 | Human | |
GEM | GTP binding protein overexpressed in skeletal muscle | 0.018 | ||
GCKR | glucokinase (hexokinase 4) regulator | 0.018 | ||
STC2 | stanniocalcin 2 | 0.018 | ||
NAB1 | NGFI-A binding protein 1 (EGR1 binding protein 1) | 0.018 | ||
ITGB8 | integrin, beta 8 | 0.018 | ||
ADRA1B | adrenergic, alpha-1B-, receptor | 0.018 | ||
LHB | luteinizing hormone beta polypeptide | 0.018 | ||
LOXL2 | lysyl oxidase-like 2 | 0.018 | ||
PLEKHA4 | pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4 | 0.018 | ||
NDUFA11 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa | 0.018 | ||
HNRNPCL1 | heterogeneous nuclear ribonucleoprotein C-like 1 | 0.018 | ||
PVR | poliovirus receptor | 0.018 | ||
CRHBP | corticotropin releasing hormone binding protein | 0.018 | ||
FAM129A | family with sequence similarity 129, member A | 0.018 | ||
ELANE | elastase, neutrophil expressed | 0.018 | ||
TIAM1 | T-cell lymphoma invasion and metastasis 1 | 0.018 |